PDA Letter Article

Join Us at the 2023 Visual Inspection Forum

by John Shabushnig, PhD, Insight Pharma Consulting, and Romain Veillon, GSK

On behalf of the Scientific Program Planning Committee and PDA, we are looking forward to welcoming you to the 2023 PDA Visual Inspection Forum in Baltimore, MD, on April 17-18, 2023! We have been working hard on this upcoming conference to keep you current with advances in inspection technology and the ever-changing regulatory landscape, and we are excited to be back to a live, in-person meeting format.

Visual inspection and the detection of particles remains at the center of many discussions regarding product manufacturing control, quality assurance and regulatory compliance. However, we continue to see product recalls related to visual defects. Moreover, inspection methods and technology continue to advance, and the application of artificial intelligence and deep learning to automated inspection have been an exciting area of recent deployment. Among other topics featured at this year’s forum, we will cover the results from the new PDA benchmarking survey on visual inspection practices.

Since 2000, we have organized the Visual Inspection Forum to discuss new technical and regulatory developments in this field. We are pleased to have experts to discuss new developments in the field of visual inspection. Topics include the regulatory and compendial requirements for visual inspection, like those found in the revised EU GMP Annex 1: Manufacture of Sterile Medicinal Products, USP <1790> and the new FDA Guidance. Additional topics include a basic understanding of the inspection process, particle characterization, special requirements for difficult to inspect products, CCIT methods, control strategies applied to visual inspection, practical aspects of manual and automated inspection methods, and case studies from visual inspection end users. The full conference program is available here.

The PDA Visual Inspection Forum program is intended to initiate and support discussion and professional exchange through a diversity of scientific presentations, posters and networking events.

We look forward to seeing you in Baltimore!

About the Author

John ShabushnigJohn Shabushnig, PhD, is the founder of Insight Pharma Consulting and an expert in visual inspection. Before starting his consulting firm, he managed microbiology and aseptic manufacturing technical support for Pfizer’s Global Quality Operations. John is an active PDA member who served as Chair of the Board of Directors and Chair of the Science Advisory Board. He organizes and leads the Visual Inspection Interest Group and is also an instructor at PDA's Training and Research Institute. John serves on the USP Dosage Forms Expert Committee and Chair of the Visual Inspection of Parenterals Expert Panel. He is a co-author of the recently published book Visual Inspection and Particulate Control.

Romain VeillonRomain Veillon, PharmD, is the Director of Vision Technology at GSK. As an expert in visual inspection, he is leading visual inspection performance and expertise network on multiple sites. For the past 24 years, Romain has worked in parenteral manufacturing and gained experience at Sanofi Pasteur, Eli Lilly and GSK, supporting production and secondary operations projects for filling and freeze-drying. In 2017, Romain developed a PDA course called "Mastering AVI", and since 2018, he has been an interest group leader for visual inspection in PDA Europe. Since 2019, Romain co-leads a taskforce to prepare a point to consider document for artificial intelligence applied to visual inspection. In 2020, Romain received the PDA James P. Agalloco Award for educational training.